How Can Mitochondrial Dna Deletions Act As A Biomarker for the Detection of Endometriosis Within the Clinic?

Jennifer Creed, Creed JM, Jennifer M Creed, Andrea Maggrah, Maggrah A, Usher R, Robert Usher, Elise Desa, Desa E, Andrew Harbottle, Harbottle A
Biomarkers in medicine · 2019 · vol. 14(1) , pp. 5–8 · doi:10.2217/bmm-2019-0435 · PMID:31686548 · W2986299521
article OA: hybrid CC0 ⤵ 3 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

Large-scale deletions within the mitochondrial genome represent a promising biomarker for endometriosis detection, potentially overcoming limitations of existing diagnostic methods.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

these features of the mitochondrial genome, its mutated subtypes and especially large-scale deletions, potentially resolve limitations of endometriosis biomarkers of different origins and offer the promise of successful translation to clinical application.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Biomarkers DNA, Mitochondrial Endometriosis Mutation Sequence Deletion Biomarkers Disease Progression DNA, Mitochondrial DNA, Mitochondrial Endometriosis Endometriosis Female Humans

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (17)

Cited by (4)

Source provenance

europepmc
last seen: 2026-07-30T06:25:42.655704+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:22:29.487098+00:00
License: CC0 · commercial use OK